Article Details

Biohaven's zavegepant nasal spray set to reach projected worth of $206.8m in 2030

Retrieved on: 2022-05-26 16:34:36

Tags for this article:

Click the tags to see associated articles and topics

Biohaven's zavegepant nasal spray set to reach projected worth of $206.8m in 2030. View article details on hiswai:

Excerpt

The NDA approval was supported by data from two pivotal double-blind, ... Migraine Drug Market Size, Share & Trends Analysis and Forecast by ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up